Exploring unchartered metagenomic sequence space in collaboration with big pharma and leading academics for over a decade, Prozomix offers the largest, most diverse and free-to- screen Biocatalysis Enzyme Toolkit for API synthesis on the global market. A combined R&D and manufacturing site, purchased by Prozomix and built-out specifically in response to customer demand, now offers seamless scaled-hit production to kgs dry powder within 1 week of request, and has cemented a global reputation for de-risking early stage bioprocess development. A private, profitable and progressive UK entity, Prozomix is a trusted choice for novel enzyme discovery and production all the way to commercial manufacture.